MedTrace Logo

Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis

NCT05519553 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-09-01

No results posted yet for this study

Summary

A mixed methods randomized controlled trial pilot study to assess peer support impact on relapsing-remitting multiple sclerosis patients' therapeutic adherence.

Conditions

  • Multiple Sclerosis, Relapsing-remitting

Interventions

OTHER

Peer support

: 1 hour individual session with a peer support specialist at 1, 3 and 5 months after baseline

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Leïla Moret, MD - PhD · Nantes University Hospital

  • Sandrine Wiertlewski, MD · Nantes University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-03-01
Completion
2026-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05519553 on ClinicalTrials.gov